Cargando…

Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows

BACKGROUND: The risk of cancer treatment‐related acute exacerbation (AE) in patients with lung cancer and mild interstitial lung disease (ILD) on imaging, classified as indeterminate for usual interstitial pneumonia (UIP), has not previously been clarified. METHODS: We retrospectively reviewed the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahara, Yutaka, Tanaka, Takuya, Ishige, Yoko, Shionoya, Ikuyo, Yamamura, Kouichi, Sakuma, Takashi, Nishiki, Kazuaki, Nakase, Keisuke, Nojiri, Masafumi, Kato, Ryo, Shinomiya, Shohei, Fujimoto, Yuki, Oikawa, Taku, Mizuno, Shiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520810/
https://www.ncbi.nlm.nih.gov/pubmed/34409749
http://dx.doi.org/10.1111/1759-7714.14121
_version_ 1784584749670465536
author Takahara, Yutaka
Tanaka, Takuya
Ishige, Yoko
Shionoya, Ikuyo
Yamamura, Kouichi
Sakuma, Takashi
Nishiki, Kazuaki
Nakase, Keisuke
Nojiri, Masafumi
Kato, Ryo
Shinomiya, Shohei
Fujimoto, Yuki
Oikawa, Taku
Mizuno, Shiro
author_facet Takahara, Yutaka
Tanaka, Takuya
Ishige, Yoko
Shionoya, Ikuyo
Yamamura, Kouichi
Sakuma, Takashi
Nishiki, Kazuaki
Nakase, Keisuke
Nojiri, Masafumi
Kato, Ryo
Shinomiya, Shohei
Fujimoto, Yuki
Oikawa, Taku
Mizuno, Shiro
author_sort Takahara, Yutaka
collection PubMed
description BACKGROUND: The risk of cancer treatment‐related acute exacerbation (AE) in patients with lung cancer and mild interstitial lung disease (ILD) on imaging, classified as indeterminate for usual interstitial pneumonia (UIP), has not previously been clarified. METHODS: We retrospectively reviewed the clinical records of 27 patients with lung cancer and ILD who were diagnosed and treated from April 2016 to March 2021. RESULTS: Among the 27 patients, 21 were classified as indeterminate for UIP and six as UIP/probable UIP; furthermore, 10 (46.6%) and three (50%) patients from each group, respectively, developed treatment‐related AEs. No significant difference was observed regarding the incidence of AEs between the two groups. However, significantly more patients in the AE group received immune checkpoint inhibitors (ICIs) compared to the non‐AE group (p = 0.021). Multivariate analysis revealed that the use of ICIs was a significant independent risk factor for treatment‐related AEs. CONCLUSIONS: Lung cancer patients with mild ILD suggestive of indeterminate for UIP and UIP patterns are at an increased risk for treatment‐related AEs. Furthermore, ICI use is an independent risk factor for AEs in patients with lung cancer complicated by ILD, and ICIs should be used with great caution.
format Online
Article
Text
id pubmed-8520810
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-85208102021-10-25 Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows Takahara, Yutaka Tanaka, Takuya Ishige, Yoko Shionoya, Ikuyo Yamamura, Kouichi Sakuma, Takashi Nishiki, Kazuaki Nakase, Keisuke Nojiri, Masafumi Kato, Ryo Shinomiya, Shohei Fujimoto, Yuki Oikawa, Taku Mizuno, Shiro Thorac Cancer Original Articles BACKGROUND: The risk of cancer treatment‐related acute exacerbation (AE) in patients with lung cancer and mild interstitial lung disease (ILD) on imaging, classified as indeterminate for usual interstitial pneumonia (UIP), has not previously been clarified. METHODS: We retrospectively reviewed the clinical records of 27 patients with lung cancer and ILD who were diagnosed and treated from April 2016 to March 2021. RESULTS: Among the 27 patients, 21 were classified as indeterminate for UIP and six as UIP/probable UIP; furthermore, 10 (46.6%) and three (50%) patients from each group, respectively, developed treatment‐related AEs. No significant difference was observed regarding the incidence of AEs between the two groups. However, significantly more patients in the AE group received immune checkpoint inhibitors (ICIs) compared to the non‐AE group (p = 0.021). Multivariate analysis revealed that the use of ICIs was a significant independent risk factor for treatment‐related AEs. CONCLUSIONS: Lung cancer patients with mild ILD suggestive of indeterminate for UIP and UIP patterns are at an increased risk for treatment‐related AEs. Furthermore, ICI use is an independent risk factor for AEs in patients with lung cancer complicated by ILD, and ICIs should be used with great caution. John Wiley & Sons Australia, Ltd 2021-08-18 2021-10 /pmc/articles/PMC8520810/ /pubmed/34409749 http://dx.doi.org/10.1111/1759-7714.14121 Text en © 2021 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Takahara, Yutaka
Tanaka, Takuya
Ishige, Yoko
Shionoya, Ikuyo
Yamamura, Kouichi
Sakuma, Takashi
Nishiki, Kazuaki
Nakase, Keisuke
Nojiri, Masafumi
Kato, Ryo
Shinomiya, Shohei
Fujimoto, Yuki
Oikawa, Taku
Mizuno, Shiro
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
title Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
title_full Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
title_fullStr Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
title_full_unstemmed Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
title_short Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
title_sort risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520810/
https://www.ncbi.nlm.nih.gov/pubmed/34409749
http://dx.doi.org/10.1111/1759-7714.14121
work_keys_str_mv AT takaharayutaka riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT tanakatakuya riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT ishigeyoko riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT shionoyaikuyo riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT yamamurakouichi riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT sakumatakashi riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT nishikikazuaki riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT nakasekeisuke riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT nojirimasafumi riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT katoryo riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT shinomiyashohei riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT fujimotoyuki riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT oikawataku riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows
AT mizunoshiro riskfactorsforacuteexacerbationinlungcancercomplicatedbyinterstitiallungdiseasewithslightreticularshadows